Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.

Némati F, de Montrion C, Lang G, Kraus-Berthier L, Carita G, Sastre-Garau X, Berniard A, Vallerand D, Geneste O, de Plater L, Pierré A, Lockhart B, Desjardins L, Piperno-Neumann S, Depil S, Decaudin D.

PLoS One. 2014 Jan 13;9(1):e80836. doi: 10.1371/journal.pone.0080836. eCollection 2014.

2.

Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

van den Bosch T, Kilic E, Paridaens D, de Klein A.

Dermatol Res Pract. 2010;2010:360136. doi: 10.1155/2010/360136. Epub 2010 Jun 6.

3.

Analysis of Bcl-2 protein expression in choroidal melanomas.

Hussein MR.

J Clin Pathol. 2005 May;58(5):486-9.

4.

Deregulation of the Rb and p53 pathways in uveal melanoma.

Brantley MA Jr, Harbour JW.

Am J Pathol. 2000 Dec;157(6):1795-801.

5.

c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.

Chana JS, Wilson GD, Cree IA, Alexander RA, Myatt N, Neale M, Foss AJ, Hungerford JL.

Br J Ophthalmol. 1999 Jan;83(1):110-4.

6.

Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Coupland SE, Bechrakis N, Schüler A, Anagnostopoulos I, Hummel M, Bornfeld N, Stein H.

Br J Ophthalmol. 1998 Aug;82(8):961-70.

Items per page

Supplemental Content

Write to the Help Desk